Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Highlights

Highlights October 2016 In This Issue Volume 73, Number 10 Pages 1165-1264 JAMA Neurology Research Clinical Review & Education JAMA Neurology Clinical Challenge Brain Atrophy in Super-refractory Status Epilepticus 1201 Hocker and coauthors document and quantify the development of atrophy over time in super-refractory status epilepticus (SRSE). This retrospective medical record review in- cluded all patients with SRSE who were admitted to a tertiary referral campus of the Mayo Clinic Hospital with SRSE from January 1, 2001, to December 31, 2013. Atrophy developed in all patients with SRSE who underwent serial imaging, despite administration of agents for seizure control. The degree of atrophy appears to be related to the duration of SRSE. Editorial perspective is provided by Andrew J. Cole, MD. Editorial 1182 Continuing Medical Education jamanetworkcme.com 1243 What is your diagnosis? Serum Docosahexaenoic Acid and Cerebral Amyloidosis 1208 Yassine and colleagues determine the association between serum docosahexaenoic acid Images in Neurology (DHA) levels, cerebral amyloidosis, and the volumes of brain areas aff ected by Alzheimer disease. They performed a cross-sectional analysis of serum DHA levels together with measures of amyloid deposition (Pittsburgh Compound B index), brain volumes, and neu- ropsychological testing scores from 61 participants in the Aging Brain http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Highlights

JAMA Neurology , Volume 73 (10) – Oct 1, 2016

Highlights

Abstract

October 2016 In This Issue Volume 73, Number 10 Pages 1165-1264 JAMA Neurology Research Clinical Review & Education JAMA Neurology Clinical Challenge Brain Atrophy in Super-refractory Status Epilepticus 1201 Hocker and coauthors document and quantify the development of atrophy over time in super-refractory status epilepticus (SRSE). This retrospective medical record review in- cluded all patients with SRSE who were admitted to a tertiary referral campus of the Mayo Clinic Hospital with...
Loading next page...
 
/lp/american-medical-association/highlights-KrKAjWBPPQ

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2015.2485
Publisher site
See Article on Publisher Site

Abstract

October 2016 In This Issue Volume 73, Number 10 Pages 1165-1264 JAMA Neurology Research Clinical Review & Education JAMA Neurology Clinical Challenge Brain Atrophy in Super-refractory Status Epilepticus 1201 Hocker and coauthors document and quantify the development of atrophy over time in super-refractory status epilepticus (SRSE). This retrospective medical record review in- cluded all patients with SRSE who were admitted to a tertiary referral campus of the Mayo Clinic Hospital with SRSE from January 1, 2001, to December 31, 2013. Atrophy developed in all patients with SRSE who underwent serial imaging, despite administration of agents for seizure control. The degree of atrophy appears to be related to the duration of SRSE. Editorial perspective is provided by Andrew J. Cole, MD. Editorial 1182 Continuing Medical Education jamanetworkcme.com 1243 What is your diagnosis? Serum Docosahexaenoic Acid and Cerebral Amyloidosis 1208 Yassine and colleagues determine the association between serum docosahexaenoic acid Images in Neurology (DHA) levels, cerebral amyloidosis, and the volumes of brain areas aff ected by Alzheimer disease. They performed a cross-sectional analysis of serum DHA levels together with measures of amyloid deposition (Pittsburgh Compound B index), brain volumes, and neu- ropsychological testing scores from 61 participants in the Aging Brain

Journal

JAMA NeurologyAmerican Medical Association

Published: Oct 1, 2016

There are no references for this article.